The rising prevalence in GLP-1 agonists for metabolic health has sparked a debate about delivery routes : transdermal systems versus tablets . Traditionally , GLP-1 drugs were exclusively available in https://hamzahkafr158478.bloggadores.com/39789792/glp-1-transdermal-delivery-systems-vs-pills-which-suitable-for-the-patient